InvestorsHub Logo
Followers 4
Posts 115
Boards Moderated 0
Alias Born 07/28/2014

Re: None

Friday, 12/12/2014 1:58:49 PM

Friday, December 12, 2014 1:58:49 PM

Post# of 346311
FDA approved ramucirumab (Cyramza Injection, Eli Lilly and Company) for use in combination with docetaxel for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with disease progression on or after platinum-based chemotherapy. December 12, 2014. More Information: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm426735.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News